OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Alzheimers Disease is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Neurobiology of COVID-19	291
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease	183
Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias	142
The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer’s Disease During the COVID-19 Crisis	109
Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer’s Disease: A Systematic Review	96
Potential Novel Role of COVID-19 in Alzheimer’s Disease and Preventative Mitigation Strategies	94
Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial	93
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer’s Disease or Mild Cognitive Impairment	88
Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey	87
Association of COVID-19 with New-Onset Alzheimer’s Disease	82
Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction	77
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases	76
Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data	75
Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study	75
The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis	74
Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline	73
SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer’s Disease	72
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease	72
The Trajectory of Caregiver Burden and Risk Factors in Dementia Progression: A Systematic Review	69
Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment	69
Promoting Successful Cognitive Aging: A Ten-Year Update	69
Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention	68
Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer’s Disease: A Systematic Review	64
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications	63
Alzheimer’s Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains	62

Air Pollution and Alzheimer’s Disease: A Systematic Review and Meta-Analysis	61
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures	60
Is Alzheimer’s Disease a Liver Disease of the Brain?	60
Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial	59
Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease	59
Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Tr	58
The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review	58
NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease	57
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management	55
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration	53
Brain Perfusion Change in Patients with Mild Cognitive Impairment After 12 Months of Aerobic Exercise Training	53
Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial	51
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care	50
tRNA-Derived Fragments in Alzheimer’s Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms	50
The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease	50
One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment	49
Impact of Social Isolation on People with Dementia and Their Family Caregivers	49
The Potential Role of Ferroptosis in Alzheimer’s Disease	46
The Role of Microglia in Sporadic Alzheimer’s Disease	45
Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study	45